Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers
- PMID: 28581817
- PMCID: PMC6435342
- DOI: 10.1089/dia.2016.0375
Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers
Abstract
Background: Managing type 1 diabetes (T1D) in young children presents challenges to families and caregivers. Pump therapy may reduce challenges and benefit glycemic control. However, pump use is not universal; parent-reported reasons for lack of uptake are not well described.
Methods: Parents of children <7, with T1D for ≥1 year, in the T1D Exchange registry completed surveys capturing demographic and clinical characteristics, as well as barriers to pump use. Data from pump users were compared to nonusers, and barriers were analyzed among parents who received pump recommendations, but decided against uptake.
Results: Young children (N = 515) from 41 sites were identified (mean age 5.2 ± 1.2 years, diabetes duration 2.4 ± 1.0 years, 46% female, and 78% Non-Hispanic White). Overall glycemic control was suboptimal (HbA1c 8.1% ± 1.0%). The majority were pump users (64%, n = 331; nonusers 36%, n = 184). Pump users had longer T1D duration (2.5 ± 1.1 years vs. 2.2 ± 1.0 years, P = 0.001), were more likely to have annual household incomes ≥$75,000 (62% vs. 36%, P < 0.001), have a parent with college education or higher (70% vs. 45%, P < 0.001), perform more frequent blood glucose monitoring (7.5 ± 2.5 times/day vs. 6.5 ± 2.3 times/day, P < 0.001), and use continuous glucose monitoring (CGM) (45% vs. 13%, P < 0.001). Only income, education, frequency of blood glucose monitoring, and CGM use remained significant in a multivariate model including age, sex, ethnicity, and duration of diabetes. Barriers to pump uptake included concerns with physical interference, therapeutic effectiveness, and to a lesser extent, financial burden.
Conclusions: These findings provide an opportunity to address potentially modifiable parent-reported barriers to pump uptake through education and behavioral intervention.
Keywords: Barriers; Insulin pump adoption; Insulin pump use; Young children.
Conflict of interest statement
P.V.C., C.T.B., K.M.M., M.G.M., D.J.D., M.A.V.N., B.J.A. and have no relevant financial disclosures. L.A.D has received consultancy fees from Sanofi-Aventis and her nonprofit employer has received grants from Novo Nordisk and Medtronic. W.V.T. has received consultancy fees from Novo Nordisk, Sanofi, and Medtronic. L.M.L. has received consultancy fees from Dexcom Inc., Eli Lilly and company, Johnson & Johnson, MannKind Corporation, Novo Nordisk Inc., Roche Diagnostics, Sanofi U.S., and Insulet.
References
-
- Weinzimer SA, Swan KL, Sikes KA, Ahern JH: Emerging evidence for the use of insulin pump therapy in infants, toddlers, and preschool-aged children with type 1 diabetes. Pediatr Diabetes 2006;7 Suppl 4:15–19 - PubMed
-
- Siminerio LM, Albanese-O'Neill A, Chiang JL, et al. : Care of young children with diabetes in the child care setting: a position statement of the American Diabetes Association. Diabetes Care 2014;37:2834–2842 - PubMed
-
- Silverstein J, Klingensmith G, Copeland K, et al. : Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005;28:186–212 - PubMed
-
- Ahern JA, Boland EA, Doane R, et al. : Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes 2002;3:10–15 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
